Timothy Compton

Mr. Compton brings over twenty-five years of industry experience with an extensive background in leading commercial operations. Before joining Alcami, Mr. Compton was the Chief Commercial Officer at Avid Bioservices, Inc. (NASDAQ: CDMO), a contract large molecule bulk drug substance development and manufacturer. From 2015 to 2019, Mr. Compton was the Vice President of Sales and Marketing at Avista Pharma, a private equity-backed global provider of contract manufacturing, development, and analytical testing services acquired by Cambrex. Mr. Compton also served in numerous executive leadership roles at AAIPharma Services Corporation, a predecessor company to Alcami, from 2010 to 2014. During the first 10-years of his career, he supported small innovator biotech/pharma start-up companies, advancing drugs from discovery to the clinic. Prior to embarking on a career in commercial operations, his last scientific role was Director of Analytical Development at Kadmus Pharmaceuticals.

Timothy holds a B.S. in Microbiology from Washington State University and is an active-duty veteran of the U.S. Army.